Fukai Ryoko, Takahashi Keita, Abe Hiroyuki, Higashiyama Yuichi, Doi Hiroshi, Takeuchi Hideyuki, Tanaka Fumiaki
Department of Neurology and Stroke Medicine, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Front Neurol. 2019 Jul 19;10:763. doi: 10.3389/fneur.2019.00763. eCollection 2019.
Fingolimod acts as a functional antagonist of the sphingosine-1-phosphate receptor and is widely used for relapsing-remitting multiple sclerosis (MS). Here we report the first case of non-traumatic acute epidural hematoma in a relapsing-remitting MS patient treated with fingolimod. Fingolimod might increase the risk of hemorrhage by enhancing vasospasm and causing vascular disruption. Switching fingolimod to other disease-modifying drugs, including dimethyl fumarate, should be considered when non-traumatic hemorrhage is observed in MS patients.
芬戈莫德作为1-磷酸鞘氨醇受体的功能性拮抗剂,被广泛用于复发缓解型多发性硬化症(MS)的治疗。在此,我们报告了首例在接受芬戈莫德治疗的复发缓解型MS患者中发生的非创伤性急性硬膜外血肿。芬戈莫德可能通过增强血管痉挛和导致血管破裂来增加出血风险。当在MS患者中观察到非创伤性出血时,应考虑将芬戈莫德换用其他疾病修饰药物,包括富马酸二甲酯。